Type II Diabetes: Clinical Trials

2 trials for Type II Diabetes, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 terminated. 2 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 42Terminated 2

Follow Type II Diabetes: new trials by email Literature Review of Type II Diabetes trials Research Report on Type II Diabetes

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Januvia (Sitagliptin) in Healing Chronic Diabetic Foot Ulcers
Sitagliptin, Placebo - Type II Diabetes
Phase 4TerminatedGeorgetown University12014-01-012017-01-06
Fatty Liver Study in Patients With Type II Diabetes
DPP4 inhibitor, Pioglitazone, Lantus insulin - Type II Diabetes, Nonalcoholic Fatty Liver
Phase 4TerminatedThe University of Texas Medical Branch, Galveston52013-05-012018-07-31

Narrower conditions

Diabetes Mellitus, Type 2 (2)  ·  Non-alcoholic Fatty Liver Disease (1)

Broader conditions

Diabetes Mellitus (2)  ·  Endocrine System Diseases (2)  ·  Glucose Metabolism Disorders (2)  ·  Metabolic Diseases (2)  ·  Nutritional and Metabolic Diseases (2)  ·  Digestive System Diseases (1)  ·  Fatty Liver (1)  ·  Liver Diseases (1)

Interventions

Dipeptidyl-Peptidase IV Inhibitors (1)  ·  Insulin Glargine (1)  ·  Pioglitazone (1)  ·  Sitagliptin Phosphate (1)  ·  saxagliptin (1)

Sponsors

Georgetown University (1)  ·  The University of Texas Medical Branch, Galveston (1)

Countries

United States (2)

Top investigators

Nicola Abate, MD (1)  ·  Paul J Kim, DPM (1)